Companies / Egypt

Price Controls Hamper Growth

January 2007 | BMI View

Printable version
Bookmark

Egypt's drug market was worth US$1.14bn in 2005 and is one of the largest in the Middle East and North Africa (MENA) region. However,

To read the full article, please choose one of the following options:

Subcribers please log in

Related Insight Articles

Patented Drug Spending To Reach US$2.5bn By 2014

Industry / Egypt BMI calculates that the value of Egypt's patented drug market will rise from US$1.60bn in 2009 to US$2.5bn by 2014, representing a compound annual growth rate (CAGR) of 9.6%. By 2019 this figure will...

January 2010

Patented Drug Spending To Reach US$2.5bn By 2014

January 2010

EIPICO Plans To Export 35% Of Its Medicines By 2015

Industry / Egypt Egypt's largest medicine exporter - Egyptian International Pharmaceutical Industries Co (EIPICO) - has announced that it will increase its further exports by 2015, with 35% of its products destined abroad....

January 2010

EIPICO Plans To Export 35% Of Its Medicines By 2015

January 2010

Generic Drug Prices Affected By New Legislation

Industry / Egypt Our update on Egyptian legislation regarding medicine prices will assess the impact of the revisions on the generic pharmaceutical industry in the country. The new law means that generic prices will...

December 2009